Our Pillars

What’s new

Reports and Insights

Clients form the core of our values, and we strive to maintain the reputation of a ‘Valued Knowledge Partner’

Primary Market Research (PMR)

Our in-house web-based survey tools for KOLs help our client gather real-time data, market trends, and critical strategic insights. Global KOL Panel Management System comprises directories of Trial Investigators, Researchers, Healthcare Practitioners (HCPs), Payers, Regulatory bodies, and Conference Speakers. The tools provide flexibility to interact with interviewers anytime.

Therapy Area Expertise

Our teams comprise experienced market researchers, epidemiologists, market forecasters, PhDs, doctors, nurse practitioners, pharmacists, business consultants, and technology consultants with AI/ML expertise. Given the combination of therapy area and industry expertise for our team members, with the cumulative experience of 1,000+ years, we strive to deliver the best results for each project.

Market Forecasting

User-friendly forecast models and tools are built based on bottom-up and top-down methodologies, and they evaluate market trends, analogs, and various macro and micro indicators that possibly impact the current and future market.

24×7 Online Support

Integration of Thelansis Global support team across continents offers support round the clock for all locations, no matter which region or country you are in.

Interactive Platform

Our multiple report offerings are available on an interactive web-based platform to quickly filter and analyze relevant data.

Customized Offerings

We often customize our syndicated report content to suit client needs.

0+

Years Experience

0+

Experts

0+

Physicians in Panel

0+

Payers in Panel

0

Global Delivery Centers

0

Delivered Market Outlook Reports in 2024

Client Reviews

Hear from happy customers about their experience working with us.

“Support on current drug utilizations and benchmarking of emerging therapy, greatly helped us in narrowing down on patient share estimations for internal calculations ״

Santen PharmaDirector

“Patient share for approved therapies are estimated perfectly. Indeed it's great pieces of work. I liked the way segmentation was shown and patient flow was discussed״

Vicore PharmaDirector

“Happy to read the market insight report, really informative and applied to build marketing strategy״

NewronDirector

“This is the first time I worked with Thelansis, I could say the team is truly professional, Cheers guys ״

SanquinDirector

“ We want to congratulate team Thelansis for their continuous support during this tough time ״

WEX TherapeuticsDirector

"We are really fortunate to interact with Thelansis' Forecasting team, well seasoned professionals who understand what's the actual need "

Reata PharmaceuticalsVice President

" We are really fortunate to interact with Thelansis' Forecasting team, well seasoned professionals who understand what's the actual need "

Stemline TherapeuticsVice President- Marketing

"Some great piece of patient based forecast model; and market assumptions. Tying up beautifully with the payer's insights "

CamurusDirector

"Liked the way the outcome was structured. Regulatory assessment was spot-on. Country-wise regulatory scenarios were gold to us at this point"

Asarina PharmaDirector

"Satisfied with the companies core competency around Clinical Trial Outcome analysi"

Acadia PharmaceuticalsDirector